For at undgå at forsinke diagnosticering og for at mindske risikoen for en livstruende overfølsom - hedsreaktion, skal Kivexa seponeres permanent, hvis overfølsomhed ikke kan udelukkes, selv når andre diagnoser er mulige (luftvejssygdomme, influenzalignende sygdom, gastroenteritis eller overfølsomhed over for andre lægemidler).
To avoid a delay in diagnosis and minimise the risk of a life-threatening hypersensitivity reaction, Kivexa must be permanently discontinued if hypersensitivity cannot be ruled out, even when other diagnoses are possible (respiratory diseases, flu-like illness, gastroenteritis or reactions to other medicinal products).